the third annual medical device regulatory, reimbursement and compliance congress
DESCRIPTION
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress. Beyond the DOJ: Compliance Best Practices in the Orthopedic Environment March 26-28, 2008. Discussion Agenda. Issues in Question in Industry Investigations. - PowerPoint PPT PresentationTRANSCRIPT
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress
Beyond the DOJ: Compliance Best Practices in the Orthopedic
Environment
March 26-28, 2008
22
Discussion AgendaDiscussion Agenda
Issues in Question in Industry Issues in Question in Industry Investigations.Investigations.
Use of Deferred Prosecution Agreements Use of Deferred Prosecution Agreements to Assure Compliance Best Practices.to Assure Compliance Best Practices.
Compliance safeguards relating to HCP Compliance safeguards relating to HCP Consulting Arrangements.Consulting Arrangements.
Other Industry Compliance Safeguards Other Industry Compliance Safeguards relating to HCP and Hospital Customers.relating to HCP and Hospital Customers.
33
Issues In InvestigationsIssues In Investigations
HCP Arrangements: consulting, product HCP Arrangements: consulting, product development, clinical research. development, clinical research.
HCP arrangements to maintain or grow HCP arrangements to maintain or grow business, move market share. business, move market share.
Entertainment, meals, gifts to HCPs and Entertainment, meals, gifts to HCPs and customers.customers.
Transparency, Disclosure, Management of Transparency, Disclosure, Management of Conflict of Interest. Conflict of Interest.
44
Deferred Prosecution AgreementsDeferred Prosecution Agreements
IntermuneIntermune
PfizerPfizer
New Jersey USAO Orthopedic Device New Jersey USAO Orthopedic Device CasesCases
Jazz PharmaceuticalsJazz Pharmaceuticals
55
DOJ Use of Monitors DOJ Use of Monitors March 7, 2008 PolicyMarch 7, 2008 Policy
Avoid Conflict of Interest.Avoid Conflict of Interest.
Assure Independence.Assure Independence.
Focus Scope of Monitor Work On Conduct Focus Scope of Monitor Work On Conduct at Issue.at Issue.
66
DOJ Use of Monitors DOJ Use of Monitors March 7, 2008 PolicyMarch 7, 2008 Policy
Appropriate Monitor Communications to Appropriate Monitor Communications to Government.Government.
Company Right to Accept or Reject Company Right to Accept or Reject Monitor’s Recommendations.Monitor’s Recommendations.
77
DOJ Use of Monitors DOJ Use of Monitors March 7, 2008 PolicyMarch 7, 2008 Policy
Monitor Disclosure of Misconduct To Monitor Disclosure of Misconduct To Government. Government.
Duration and Extension Of Monitor Duration and Extension Of Monitor Arrangement.Arrangement.
88
Before the DPA/CIA: Lessons LearnedBefore the DPA/CIA: Lessons Learned
The relative subjectivity of an effective The relative subjectivity of an effective compliance program.compliance program.
Preparing for “extreme” transparency.Preparing for “extreme” transparency.
One size fits all?One size fits all?
Industry-wide versus individual entity Industry-wide versus individual entity resolution agreements: advantages and resolution agreements: advantages and challenges.challenges.
99
Operationalizing a DPAOperationalizing a DPA
DPA versus compliance program DPA versus compliance program implementation: high stakes for mistakes.implementation: high stakes for mistakes.
The potential quagmire of retrospection.The potential quagmire of retrospection.
Scope of a DPA.Scope of a DPA.
Post-DPA training needs.Post-DPA training needs.
Emotional reactions of different Emotional reactions of different constituencies.constituencies.
1010
The Tipping Point: Going Beyond the The Tipping Point: Going Beyond the DPA/CIADPA/CIA
Building and sustaining a burning platform.Building and sustaining a burning platform.
The future is now: prognosticating The future is now: prognosticating compliance/enforcement trends.compliance/enforcement trends.
Speed of change: Speed of change:
– Can the trajectory be too fast? What if it is not fast Can the trajectory be too fast? What if it is not fast enough?enough?
– How can the compliance function become more How can the compliance function become more agile? agile?
– How do you build the boat while you are trying to row How do you build the boat while you are trying to row it?it?
1111
Uncharted Territory: The Transactional Uncharted Territory: The Transactional Compliance ModelCompliance Model
Potential Conflicts.Potential Conflicts.
Potential Advantages.Potential Advantages.
Special Recruiting Needs:Special Recruiting Needs:
– LegalLegal
– FinancialFinancial
– Compliance as a profession Compliance as a profession
1212
Two is (not always) better than One: Two is (not always) better than One: Navigating a DPA and CIANavigating a DPA and CIA
Complementary/discrete philosophies.Complementary/discrete philosophies.
Short term challenges.Short term challenges.
Long term advantages.Long term advantages.
First impression issues for Independent First impression issues for Independent Review Organizations.Review Organizations.
1313
Compliance Safeguards for HCP Compliance Safeguards for HCP CollaborationsCollaborations
Needs Assessment documented for all money Needs Assessment documented for all money flowing to HCPs. flowing to HCPs.
Documented payment for performance. Documented payment for performance.
Sales Force Firewall for all non-product Sales Force Firewall for all non-product activities. activities.
Re-structure product development teams and Re-structure product development teams and compensation. compensation.
No entertainment or gifts. No entertainment or gifts.
1414
Other Industry Compliance InitiativesOther Industry Compliance Initiatives
Hospital Conflict of Interest Policies. Hospital Conflict of Interest Policies.
AAOS Standards of Professionalism, April AAOS Standards of Professionalism, April 2007 2007
Physician Network Conflict of Interest Policies. Physician Network Conflict of Interest Policies.
AdvaMed-Beyond Code of Ethics: Payment AdvaMed-Beyond Code of Ethics: Payment Sunshine Act and disclosure standards.Sunshine Act and disclosure standards.
1515
Contact InformationContact Information
Kathleen McDermott, EsquireKathleen McDermott, EsquireSonnenschein Nath & Rosenthal LLPSonnenschein Nath & Rosenthal LLPWashington, DCWashington, DC(202) 408-3274(202) [email protected]@sonnenschein.com
Laura O’Donnell, EsquireLaura O’Donnell, EsquireZimmer Holdings, Inc.Zimmer Holdings, Inc.Warsaw, IN 46580-2746Warsaw, IN 46580-2746(574) 371-8637(574) [email protected]@zimmer.com